Inhibition of Dll4 Signalling Inhibits Tumour Growth by Deregulating Angiogenesis.
From: Tumor Biology & Angiogenesis, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, USA.
Nature
- Publish Date: Dec 2006
- ISSN: 1476-4687
- Volume: 444
- Issue: 7122
- Pages: 1083-7
- Medium: Internet
- Language: English
- Citation (JAMA): Ridgway John, Zhang Gu, Wu Yan, et al. Inhibition of Dll4 Signalling Inhibits Tumour Growth by Deregulating Angiogenesis.. Nature Dec 2006;444:1083-7
Abstract
Haploinsufficiency of Dll4, a vascular-specific Notch ligand, has shown that it is essential for embryonic vascular development and arteriogenesis. Mechanistically, it is unclear how the Dll4-mediated Notch pathway contributes to complex vascular processes that demand meticulous coordination of multiple signalling pathways. Here we show that Dll4-mediated Notch signalling has a unique role in regulating endothelial cell proliferation and differentiation. Neutralizing Dll4 with a Dll4-selective antibody rendered endothelial cells hyperproliferative, and caused defective cell fate specification or differentiation both in vitro and in vivo. In addition, blocking Dll4 inhibited tumour growth in several tumour models. Remarkably, antibodies against Dll4 and antibodies against vascular endothelial growth factor (VEGF) had paradoxically distinct effects on tumour vasculature. Our data also indicate that Dll4-mediated Notch signalling is crucial during active vascularization, but less important for normal vessel maintenance. Furthermore, unlike blocking Notch signalling globally, neutralizing Dll4 had no discernable impact on intestinal goblet cell differentiation, supporting the idea that Dll4-mediated Notch signalling is largely restricted to the vascular compartment. Therefore, targeting Dll4 might represent a broadly efficacious and well-tolerated approach for the treatment of solid tumours.
Mesh Headings (Keywords): Animals, Cell Differentiation, Cell Line, Cell Proliferation, Endothelium, Vascular, Homeostasis, Humans, Intestine, Small, Membrane Proteins, Mice, Neoplasms, Neovascularization, Pathologic, Receptors, Notch, Signal Transduction, Vascular Endothelial Growth Factor A
Check for Full Text / PubMed Unique Identifier (PMID): 17183323
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.